Constipation is common disease which is estimated to affect each individual once in life time. According to international as well regional guidelines it is characterized by frequency and nature of bowel movement. Less than 2 bowel movements per week, associated with hard stool and strain in passing is termed as constipation. Constipation may be occasional which lasts for few weeks or may be chronic which lasts for longer period and is recurrent. It may be associated with other conditions such as irritable bowel syndrome or opioid consumption.
The Constipation market revenue was xx Million USD in 2016, grew to xx Million USD in 2021, and will reach xx Million USD in 2026, with a CAGR of xx during 2021-2026.

Considering the influence of COVID-19 on the global Constipation market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions.

This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery.

Under COVID-19 Outbreak, how the Constipation Industry will develop is also analyzed in detail in Chapter 1.8 of this report.

Major Players in Constipation market are:
Ironwood Pharmaceuticals
Prestige Brands Holdings
Abbott
Takeda Pharmaceutical
Cosmo Pharmaceuticals
Janssen Pharmaceutical
Daewoong Pharmaceuticals
Bayer
Synergy Pharmaceuticals
Sanofi
Renexxion
Sucampo Pharmaceuticals
AstraZeneca
Albireo Pharma
Bausch Health
Shionogi

Most important types of Constipation products covered in this report are:
Chronic Idiopathic Constipation (CIC)
Irritable Bowel Syndrome With Constipation (IBS-C)
Opioid-Induced Constipation (OIC)

Most widely used downstream fields of Constipation market covered in this report are:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Major Region

s or countries covered in this report:
North America
Europe
China
Japan
Middle East and Africa
South America
India
South Korea
Southeast Asia
Others

In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations.

In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out.

In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.

Years considered for this report:

Historical Years:

2016-2020

Base Year:

2020

Estimated Year:

2021

Forecast Period:

2021-2026